Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Qinqin ZUO"'
Autor:
Liangzi ZHANG, Qinqin ZUO, Dazhou WU, Yong ZHANG, Xiaoyue CHU, Weiwei ZHANG, Hong WANG, Juan MAO, Hua XU
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 10, Pp 949-952 (2023)
Objective To establish a rare blood group information supply platform in Shaanxi Province. Methods The rare blood group information supply platform consists of sample registration, result registration, donor files and inventory blood. The blood donat
Externí odkaz:
https://doaj.org/article/ec1605b77f5e4066938fa8d0e9f212f5
Autor:
Qinqin ZUO, Liangzi ZHANG, Dazhou WU, Yong ZHANG, Xiaoyue CHU, Weiwei ZHANG, Hong WANG, Juan MAO, Hua XU
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 10, Pp 928-931 (2023)
Objective To evaluate the application of monoclonal typing reagents and human anti-A/B antibodies for absorption-elution test in ABO grouping. Methods The specificity of monoclonal typing reagents and human anti-A/B antibodies with standard A, B, O a
Externí odkaz:
https://doaj.org/article/f1a4bab0010c4d608c49e1baddf4ad7e
Autor:
Xiaoyue CHU, Yong ZHANG, Juan MAO, Liangzi ZHANG, Qinqin ZUO, Weiwei ZHANG, Dazhou WU, Hong WANG, Hua XU
Publikováno v:
Zhongguo shuxue zazhi, Vol 35, Iss 11, Pp 1124-1127 (2022)
Objective To screen individuals with rare blood type of Kidd, Diego, Duffy blood group system among the voluntary blood donor in Shaanxi province and to establish on-line and physical database of rare blood type. Methods Jk(a-b-)phenotype donors were
Externí odkaz:
https://doaj.org/article/4004b0bcd50f4952b556640d383d7c32
Autor:
Liangzi ZHANG, Qinqin ZUO, Dazhou WU, Yong ZHANG, Hong WANG, Xiaoyue CHU, Juan MAO, Weiwei ZHANG, Hua XU
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 1, Pp 42-44 (2023)
Objective To observe the distribution of non-ABO-HDN and its clinical relevance, so as to provide reference for clinical diagnosis and treatment. Methods A total of 287 cases of non-ABO-HDN recorded during January 2012 to August 2022 were enrolled an
Externí odkaz:
https://doaj.org/article/8a69039ef24b451196a93646a9a531c7
Autor:
Liangzi ZHANG, Qinqin ZUO, Yong ZHANG, Dazhou WU, Weiwei ZHANG, Hong WANG, Xiaoyue CHU, Juan MAO, Hua XU
Publikováno v:
Zhongguo shuxue zazhi, Vol 35, Iss 9, Pp 963-966 (2022)
Objective To observe the distribution of the unexpected antibodies in order to study the safety and strategies in 1 779 cases of clinical blood transfusion. Methods A total of 1 779 patients with unexpected antibodies were enrolled from transfusion c
Externí odkaz:
https://doaj.org/article/a7e604f99712441fa23f545a449a43ae
Autor:
Jingwen Zhao, Chu Xiaoyue, Wenjing Wu, Hua Xu, Dazhou Wu, Wei Chen, Yong Duan, Baoyan Wang, Qinqin Zuo
Publikováno v:
Transfusion medicine (Oxford, England)REFERENCES. 30(4)
Objectives This study aimed at identifying new ABO alleles from155 unrelated blood samples with potential ABO discrepancy in a Chinese Han population of 835 144 donors. Background Serological strategies and genotyping are crucial for the precise dete
Publikováno v:
International Journal of Experimental Pathology. 96:248-254
Cortactin, the cytoplasmic substrate of HDAC6, is known to play an actin cytoskeletal regulatory role which is implicated in the motility of cancer cells, and thus in cancer progression. Its activity is found to be regulated by HDAC6. However, the si
Publikováno v:
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics. 32(1)
To investigate the molecular basis of an individual featuring weak A phenotype of ABO blood group system.Serologic investigations, serum transferases activity assay and absorption-elution test were carried out to identify the ABO blood group. The 7 e
Autor:
Le Zhao, Xue-Bin Zhang, Guanjun Zhang, Hongyan Wang, Xu Li, Huilian Hou, Xiaofeng Li, Yili Wang, Min Wang, Qinqin Zuo, Huilin Gong, Wei Chen
Publikováno v:
Journal of clinical pathology. 65(12)
Objective Cortactin acts as a prominent substrate of histone deacetylases (HDACs) and plays important roles in tumour progression in several human cancers. However, the clinical significance of its expression in human prostate cancer (PCa) has not be
Publikováno v:
Oncology reports. 27(3)
Histone deacetylase 6 (HDAC6) promotes cell motility and contributes to the metastasis of cancers. The purpose of this study was to investigate the role of HDAC6 in human bladder cancer for the first time. The results showed that HDAC6 promotes the m